Effects of Low-Dose Fluticasone Propionate/Salmeterol Combination Therapy on Exhaled Nitric Oxide and Nitrite/Nitrate in Breath Condensates from Patients with Mild Persistent Asthma

References

• Expert Panel Report 3 (EPR-3). Guidelines for the Diagnosis and Management of Asthma. NIH Publication No. 97-4051. Bethesda, MD: National Institute of Health, National Heart, Lung, and Blood Institute, 1997.
   Google Scholar
• Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987; 136:225–244.
   PubMed Web of Science ®Google Scholar
• Juniper EF, Frith PA, Hargreave FE. Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax 1981; 36(8):575–579.
   PubMedGoogle Scholar
• Fish JE, Peters SP. Airway remodeling and persistent airway obstruction in asthma. J Allergy Clin Immunol 1999; 104(3 Pt. 1):509–516.
   PubMed Web of Science ®Google Scholar
• Richter K, Holz O, Jorres RA, Mucke M, Magnussen H. Sequentially induced sputum in patients with asthma or chronic obstructive pulmonary disease. Eur Respir J 1999; 14(3):697–701.
   PubMedGoogle Scholar
• Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, Sterk PJ. Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med 2000; 161(1):309–329.
   PubMed Web of Science ®Google Scholar
• Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin AC, Plummer AL, Taylor DR. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011; 184(5):602–615.
   PubMed Web of Science ®Google Scholar
• Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998; 53(2):91–95.
   PubMed Web of Science ®Google Scholar
• Berkman N, Avital A, Breuer R, Bardach E, Springer C, Godfrey S. Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests. Thorax 2005; 60(5):383–388.
   PubMedGoogle Scholar
• Dupont LJ, Rochette F, Demedts MG, Verleden GM. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma. Am J Respir Crit Care Med 1998; 157(3 Pt. 1):894–898.
   PubMed Web of Science ®Google Scholar
• Expert Panel Report 3 (EPR-3). Guidelines for the diagnosis and management of asthma summary report 2007. J Allergy Clin Immunol 2007; 120(Suppl. 5):S94–S138.
   Google Scholar
• Perez-de-Llano LA, Carballada F, Castro AO, Pizarro M, Golpe R, Baloira A, Vazquez CM, Boquete M. Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma. Eur Respir J 2010; 35(6):1221–1227.
   PubMed Web of Science ®Google Scholar
• Prieto L, Gutierrez V, Perez-Frances C, Badiola C, Lanuza A, Bruno L, Ferrer A. Effect of fluticasone propionate-salmeterol therapy on seasonal changes in airway responsiveness and exhaled nitric oxide levels in patients with pollen-induced asthma. Ann Allergy Asthma Immunol 2005; 95(5):452–461.
   PubMedGoogle Scholar
• Gelb AF, Taylor CF, Shinar CM, Gutierrez CA, Zamel N. Effect of fluticasone 250 microg/salmeterol 50 microg and montelukast on exhaled nitric oxide in asthmatic patients. Can Respir J 2008; 15(4):193–198.
   PubMedGoogle Scholar
• Chanez P, Stallaert R, Reznikova E, Bloemen P, Adamek L, Joos G. Effect of salmeterol/fluticasone propionate combination on airway hyper-responsiveness in patients with well-controlled asthma. Respir Med 2010; 104(8):1101–1109.
   PubMedGoogle Scholar
• Wallin A, Sue-Chu M, Bjermer L, Ward J, Sandstrom T, Lindberg A, Lundback B, Djukanovic R, Holgate S, Wilson S. Effect of inhaled fluticasone with and without salmeterol on airway inflammation in asthma. J Allergy Clin Immunol 2003; 112(1):72–78.
   PubMedGoogle Scholar
• Lundback B, Ronmark E, Lindberg A, Jonsson AC, Larsson LG, Petavy F, James M. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate. Respir Med 2006; 100(1):2–10.
   PubMedGoogle Scholar
• Hozawa S, Terada M, Hozawa M. Comparison of budesonide/formoterol Turbuhaler with fluticasone/salmeterol Diskus for treatment effects on small airway impairment and airway inflammation in patients with asthma. Pulm Pharmacol Ther 2011; 24(5): 571–576.
   PubMedGoogle Scholar
• Farah CS, King GG, Brown NJ, Downie SR, Kermode JA, Hardaker KM, Peters MJ, Berend N, Salome CM. The role of the small airways in the clinical expression of asthma in adults. J Allergy Clin Immunol 2012; 129(2):381–387.
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005; 26(2):319–338.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society; European Respiratory Society. ATS/ERS Recommendations for standardized procedures for the online and offline measurements of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171:912–930.
   PubMed Web of Science ®Google Scholar
• Hunt J. Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease. J Allergy Clin Immunol 2002; 110(1): 28–34.
   PubMed Web of Science ®Google Scholar
• Feelisch M, Rassaf T, Mnaimneh S, Singh N, Bryan NS, Jourd’heuil D, Kelm M. Concomitant S-, N-, and heme-nitros(yl)ation in biological tissues and fluids: implications for the fate of NO in vivo. FASEB J 2002; 16:1775–1785.
   PubMed Web of Science ®Google Scholar
• Hunt J. Exhaled breath condensate pH assays. Immunol Allergy Clin North Am 2007; 27(4):597–606.
   PubMedGoogle Scholar
• Wilson AM, Dempsey OJ, Sims EJ, Lipworth BJ. Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids. Chest 2001; 119(4): 1021–1026.
   PubMed Web of Science ®Google Scholar
• Cockcroft DW, Swystun VA, Bhagat R, Kalra S. Salmeterol and airway response to allergen. Can Respir J 1997; 4:37–40.
   Google Scholar
• Cockcroft DW, O’Byrne PM, Swystun VA, Bhagat R. Regular use of inhaled albuterol and the allergen-induced late asthmatic response. J Allergy Clin Immunol 1995; 96(1):44–49.
   PubMedGoogle Scholar
• Montuschi P, Barnes PJ. Analysis of exhaled breath condensate for monitoring airway inflammation. Trends Pharmacol Sci 2002; 23(5):232–237.
   PubMed Web of Science ®Google Scholar
• Effros RM, Biller J, Foss B, Hoagland K, Dunning MB, Castillo D, Bosbous M, Sun F, Shaker R. A simple method for estimating respiratory solute dilution in exhaled breath condensates. Am J Respir Crit Care Med 2003; 168(12):1500–1505.
   PubMed Web of Science ®Google Scholar
• Lundberg JO, Weitzberg E. NO-synthase independent NO generation in mammals. Biochem Biophys Res Commun 2010; 396(1):39–45.
   PubMed Web of Science ®Google Scholar
• Ganas K, Loukides S, Papatheodorou G, Panagou P, Kalogeropoulos N. Total nitrite/nitrate in expired breath condensate of patients with asthma. Respir Med 2001; 95(8):649–654.
   PubMedGoogle Scholar
• Marteus H, Tornberg DC, Weitzberg E, Schedin U, Alving K. Origin of nitrite and nitrate in nasal and exhaled breath condensate and relation to nitric oxide formation. Thorax 2005; 60(3):219–225.
   PubMedGoogle Scholar
• Zetterquist W, Marteus H, Kalm-Stephens P, Nas E, Nordvall L, Johannesson M, Alving K. Oral bacteria – the missing link to ambiguous findings of exhaled nitrogen oxides in cystic fibrosis. Respir Med 2009; 103(2):187–193.
   PubMed Web of Science ®Google Scholar
• Fukushima C, Matsuse H, Tomari S, Obase Y, Miyazaki Y, Shimoda T, Kohno S. Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone. Ann Allergy Asthma Immunol 2003; 90(6):646–651.
   PubMedGoogle Scholar
• Zetterquist W, Marteus H, Hedlin G, Alving K. Increased exhaled nitrite in children with allergic asthma is not related to nitric oxide formation. Clin Respir J 2008; 2(3):166–174.
   PubMedGoogle Scholar
• Hunt J, Byrns RE, Ignarro LJ, Gaston B. Condensed expirate nitrite as a home marker for acute asthma. Lancet 1995; 346(8984):1235–1236.
   PubMedGoogle Scholar
• Formanek W, Inci D, Lauener RP, Wildhaber JH, Frey U, Hall GL. Elevated nitrite in breath condensates of children with respiratory disease. Eur Respir J 2002; 19(3):487–491.
   PubMedGoogle Scholar
• Corradi M, Pesci A, Casana R, Alinovi R, Goldoni M, Vettori MV, Cuomo A. Nitrate in exhaled breath condensate of patients with different airway diseases. Nitric Oxide 2003; 8(1):26–30.
   PubMed Web of Science ®Google Scholar
• Ojoo JC, Mulrennan SA, Kastelik JA, Morice AH, Redington AE. Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis. Thorax 2005; 60(1):22–26.
   PubMedGoogle Scholar
• Chladkova J, Krcmova I, Chladek J, Cap P, Micuda S, Hanzalkova Y. Validation of nitrite and nitrate measurements in exhaled breath condensate. Respiration 2006; 73(2):173–179.
   PubMedGoogle Scholar
• Ratnawati MJ, Henry RL, Thomas PS. Exhaled breath condensate nitrite/nitrate and pH in relation to pediatric asthma control and exhaled nitric oxide. Pediatr Pulmonol 2006; 41(10):929–936.
   PubMedGoogle Scholar
• Robroeks CM, van de Kant KD, Jobsis Q, Hendriks HJ, van Gent R, Wouters EF, Damoiseaux JG, Bast A, Wodzig WK, Dompeling E. Exhaled nitric oxide and biomarkers in exhaled breath condensate indicate the presence, severity and control of childhood asthma. Clin Exp Allergy 2007; 37(9):1303–1311.
   PubMed Web of Science ®Google Scholar
• Vogelberg C, Kahlert A, Wurfel C, Marx K, Bohm A, Range U, Neumeister V, Leupold W. Exhaled breath condensate nitrite – methodological problems of sample collection. Med Sci Monit 2008; 14(8):CR416–CR422.
   PubMedGoogle Scholar
• Rihak V, Zatloukal P, Chladkova J, Zimulova A, Havlinova Z, Chladek J. Nitrite in exhaled breath condensate as a marker of nitrossative stress in the airways of patients with asthma, COPD, and idiopathic pulmonary fibrosis. J Clin Lab Anal 2010; 24(5):317–322.
   PubMedGoogle Scholar